Urodynamic evaluation of the efficacy of vibegron, a new β3-adrenergic receptor agonist, on lower urinary tract function in children and adolescents with overactive bladder-Reference-Cited by-同舟云学术

Urodynamic evaluation of the efficacy of vibegron, a new β3-adrenergic receptor agonist, on lower urinary tract function in children and adolescents with overactive bladder

Published:2022-10 Issue:5 Volume:18 Page:563-569
ISSN:1477-5131
Container-title:Journal of Pediatric Urology
language:en
Short-container-title:Journal of Pediatric Urology

Author:

Kitta Takeya^ORCID,Chiba Hiroki,Kon Masafumi,Higuchi Madoka,Kusakabe Naohisa,Ouchi Mifuka,Togo Mio,Abe-Takahashi Yui,Tsukiyama Mayuko,Shinohara Nobuo

Publisher

Elsevier BV

Subject

Urology,Pediatrics, Perinatology and Child Health

Reference30 articles.

1. Children's experience with daytime and nighttime urinary incontinence - a qualitative exploration;Malhotra;J Pediatr Urol,2020

2. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society;Austin;Neurourol Urodyn,2016

3. Overactive bladder in children;Franco;Nat Rev Urol,2016

4. Pediatric overactive bladder syndrome: pathophysiology and management;Franco;Paediatr Drugs,2007

5. Conservative management for female urinary incontinence and pelvic organ prolapse review 2013: summary of the 5th International Consultation on Incontinence;Dumoulin;Neurourol Urodyn,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of a study examining the use of onabotulinumtoxinA in pediatric patients with overactive bladder;Journal of Pediatric Urology;2024-08

2. Current optimal pharmacologic therapies for overactive bladder;Expert Opinion on Pharmacotherapy;2023-10-05

3. Vibegron shows high efficacy in pediatric patients with refractory daytime urinary incontinence;Neurourology and Urodynamics;2023-02-25

4. Re: Urodynamic evaluation of the efficacy of vibegron, a new β3-adrenergic receptor agonist, on lower urinary tract function in children and adolescents with overactive bladder;Journal of Pediatric Urology;2022-10